$AMGN Triggered Lows NASDAQ:AMGN has alerted for a potential move lower. Target is set for 313.49. Will need some volume or wind from the market for this move.
44,533.33
0.00 BRL
33.55 B BRL
139.91 B BRL
About Amgen Inc.
Sector
Industry
CEO
Robert A. Bradway
Website
Headquarters
Thousand Oaks
Founded
1980
ISIN
BRAMGNBDR004
FIGI
BBG002H1H201
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Amgen: False Breakdown and Uptrend?Amgen has been fighting higher this year, and some traders may think a longer-term uptrend is in place.
The first pattern on today’s chart is the move under $310 after mixed quarterly results. The drugmaker quickly recovered as Wall Street focused on its pipeline. The resulting drop and rebound cou
Long OP Motivation
Bear candle is rejected.
Company outlook is bullish.
Price/earning spiral looks to establish.
AMGN - Increased Probability of AppreciationAMGN has the support of Fiboclouds indicating an increased probability of appreciation at least until the first target. The second target should be tested, provided the stop loss is properly repositioned at the time of the first partial realization.
If this projection is confirmed and a partial rea
AMGN breaking above supply and fib levelThis good be a good risk vs reward. This stock has been acting nice breaking above recent highs and fib level. Also its sector seems to be for now breaking out.
Buyback Patterns for Swing TradingNASDAQ:AMGN shows a buyback run followed by a sell day that was instigated by market makers as buyers quickly disappeared. Remember that corporate buybacks are done by bank floor traders to add stock to their inventory so they won't take profits at the peak of the run; those are other market partic
AMGN Puts 290 Strike August 16th Expiration.I believe "AMGN" will get to around 217.7ish and then dip. From a technical viewpoint I believe its showing a "head and shoulders top" based on a chart that looks back since August of 2023. I am a rookie and don't know if this is true but am basing it on that. From a fundamental viewpoint I believe
Amgen's MariTide Shakes Up Weight Loss Drug MarketThe weight loss drug market, projected to hit $100 billion by the decade's end, is undergoing significant innovation. Amidst dominant players like Novo Nordisk and Eli Lilly, Amgen is emerging with MariTide, a potentially game-changing drug set to disrupt the industry. MariTide's extended-release fo
AMGN Rises as CEO Celebrates Growth in Experimental Obesity DrugAmgen Inc.'s shares ( NASDAQ:AMGN ) rose by 15.9% when the market opened on Friday, marking its biggest intraday rise since July 2009. The company has emerged as a potential competitor to Eli Lilly & Co. and Novo Nordisk A/S, which currently dominate the weight-loss market. Demand for anti-obesity d
AMGN potential buy setupReasons for bullish bias:
- Price bounced from support
- Weekly bullish candle closing at support
- 0.5 fib retracement
Entry Level (CMP): 278.40
Stop Loss Level: 264.03
Take Profit Level 1: 292.77
Take Profit Level 2: 307.14
Take Profit Level 3: Open
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where AMGN34 is featured.
